Evidence map›Paper›PMID 34791157›Full record

ReviewEuropean heart journal2022

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.

Task Force for the management of COVID-19 of the European Society of Cardiology

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 80 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 4 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 4 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Guideline
  2. Are Pre-Hospitalization ECG Abnormalities Associated With Increased Mortality in COVID-19 Patients? A Quantitative Systematic Literature Review.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. 2024 update in heart failure.ESC heart failure · 2025
    Review
  13. Thromboembolic Events in the Era of COVID-19: A Detailed Narrative Review.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  14. Coronary Implications of COVID-19.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  15. Article
  16. SARS-CoV-2 and Environmental Changes: The Perfect Storm.Current issues in molecular biology · 2024
    Review
  17. Observational
  18. Article
  19. Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Department.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 17 institutions in 9 countries.

Task Force for the management of COVID-19 of the European Society of Cardiology
Centro Cardiologico Monzino · ITFederico II University Hospital · ITFondazione Toscana Gabriele Monasterio · ITHôpital de la Timone · FRIRCCS Ospedale San Raffaele · ITJagiellonian University · PLJessa Hospital · BELaboratoire Traitement du Signal et de l'Image · FRLeiden University Medical Center · NLOslo University Hospital · NOParis Cardiovascular Research Center · FRSpanish National Centre for Cardiovascular Research · ESSt George's, University of London · GBUnité de recherche sur les maladies cardiovasculaires et métaboliques · FRUniversity College London · GBUniversity Hospital of Bern · CHUniversity of Catania · IT

Funding

Medical Research Council MC_UU_12026/6
6 · The paper itself

Abstract

aimsSince its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19. METHODS AND

resultsA narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19.

conclusionThis comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

Indexed as

CardiologyCardiovascular DiseasesCOVID-19HumansPandemicsProspective StudiesACE2ArrhythmiasBiomarkersCardiogenic shockCOVID-19Myocardial injuryMyocarditisNon-invasive imaging

Identifiers

PMID34791157
PMCPMC8690026
OpenAlexW3217764023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.